Chagas Disease in the United States FDA BPAC meeting, 1 April 2009 Susan P. Montgomery, DVM MPH LCDR, USPHS Parasitic Diseases Branch Centers for Disease.

Slides:



Advertisements
Similar presentations
Epidemiology of Plague in the US Skin Zoonotic Diseases VM 544 Veterinary Preventive Medicine Dr. Paul Bartlett, MPH., DVM., Ph.D.
Advertisements

Page Up to Reverse  Employee Health  Page Down to Advance  Employee Health 
WHO comparative evaluation of serologic assays for Chagas disease Journal Club April 2, 2009.
Negative Effects of African Trypanosomiasis
American Trypanosomiasis Chagas Disease New World Trypanosomiasis South American Trypanosomiasis Mal de Chagas Chagas-Mazza Disease.
Chagas Disease Tabitha Martel Epidemiology November 15, 2007.
Screening of Human and Animal Sera from Egypt and Hong Kong Perera et al. Euro Surveill. 2013;18(36):pii=20574 Sampled 1343 Human, 625 animals.
Dr.T.V.Rao MD TRYPANOSOMA CRUZI TRYPANOSOMA CRUZI CHAGAS’ DISEASE DR.T.V.RAO MD 1.
Judith Pinkham (Ph.D. Student) Walden University PUBH 8165 Instructor: Dr. Fredric Grant Summer 2013.
Recent Trends in Gonorrhea in the United States Lori M. Newman, MD Division of STD Prevention CDC Jacksonville, FL May 9, 2006.
Susan N. Hocevar, MD Medical Officer Office of Blood, Organ, and Other Tissue Safety Division of Healthcare Quality and Promotion Investigation Framework.
Chagas Disease Lauren Askew. Chagas disease is characterized by fever, nausea, and diarrhea or constipation and digestive problems Anna, Moorhouse. "The.
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
CHAGAS DISEASE Lucy Shearer. Carlos Chagas discovered the disease in 1909 © Oswaldo Cruz House - Fiocruz.
‏Hepatitis B Eliminating Transmission Preventing Disease* John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention * The.
Introduction to Tickborne Diseases
Babesiosis 1 st Quarter 2011 DIDE Training Jonah Long, MPH 1.
The Chagas’ disease and its occurrence in the Amazon region of Brazil Pace Law School Science for Environmental Lawyers Spring 2004 Roseane Cerbino.
Patient: Simon Conditions: Ulcerated, raised lesions on neck, calves, and feet. Ulcerated, raised lesions on neck, calves, and feet. Lesions have drained,
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
A FIVE-YEAR INVESTIGATION OF THE SEROPOSITIVITY OF TOXOPLASMA GONDİİ IN KARS STATE HOSPITAL (KARS, TURKEY) Neriman Mor¹Atila Akça² Kafkas University Kars.
Epidemiology.
West Nile Virus Jo Hofmann, MD State Epidemiologist for Communicable Disease Washington State Department of Health Focus on clinical aspects of human infection.
Cardiovascular System Infection - Myocarditis
Analysis of Infection of Trypanosoma cruzi, Causative Agent of Chagas Disease, in Triatomine Insects from Southern Arizona Acknowledgements: Teresa Gregory,
A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.
Trypanosoma cruzi. Endemic to Mexico, South America and Central America, infecting 8-11 million people there It is associated with poverty and poor housing.
T. cruzi Incidence Study in Blood Donors and its Implications for One-time Testing of Blood Donors Robert Duncan, Ph.D. DETTD, CBER, FDA Blood Products.
1 Blood Systems Trypanosoma cruzi and Chagas Disease Studies and Potential Strategies for Targeted Testing of Donors Blood Products Advisory Committee.
Chagas Testing Icky things that can drop on you from your thatched roof! ABC 7-04.
Vector-Borne Diseases: Trypanosomiasis April 1 st, 2010.
Current Status of Issues Related to West Nile virus testing and donor screening Hira Nakhasi, Ph.D. Director, DETTD/OBRR CBER, FDA.
Trypanosoma cruzi from Opossums in Southwest Georgia and North Florida Jessica L. Gillis and J. Mitchell Lockhart Department of Biology Valdosta State.
Infectious Disease Epidemiology, Module I Introduction.
This presentation is made available through a Creative Commons Attribution- Noncommercial license. Details of the license and permitted uses are available.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Trypanosomiasis Sleeping Sickness David Humber. Trypanosomes of Vertebrates T.corvi Corvids T.cruzi Humans, rodents, marsupials T.brucei sp Man, ungulates.
Issues Related to Implementation of Blood Donor Screening for Infection with Trypanosoma cruzi Presentation to BPAC April 26, 2007 Robert Duncan, PhD.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
Case definitions & classification. Malaria case (as defined in elimination programmes) A case in which, regardless of the presence or absence of clinical.
Trypanosoma cruzi By : Sahro and Amal.
BLOOD AND INTESTINAL PROTOZOA QUICK REVIEW. Trypanosoma cruzi Disease--Chagas' disease. Characteristics—Blood and tissue protozoan. Life cycle: Trypomastigotes.
Public health impacts of donor screening for T. cruzi infection Susan P. Montgomery, DVM MPH Division of Parasitic Diseases Centers for Disease Control.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Trypanosoma cruzi in southwest Georgia raccoons Berrien R. Waters and J. Mitchell Lockhart Department of Biology Valdosta State University Valdosta, Georgia.
Aaron Manning. Overview Also called American trypanosomiasis and the Kiss of Death A tropical parasitic disease caused by the flagellate protozoan Trypanosoma.
Holland Laboratory David A. Leiby, PhD Transmissible Diseases Department American Red Cross Holland Laboratory and Department of Microbiology and Tropical.
1 Update on Study to Further Define the Incidence of T. cruzi Infection in the US Blood Donor Population Susan L. Stramer, PhD American Red Cross BPAC.
PARASITIC INFECTIONS Assoc.Prof.Dr.Yesim Gürol. Five hunters spent a weekend in a cabin in the Northeastern United States. One of the hunters, who slept.
Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.
Giardiasis Giardia Enteritis Lambliasis Beaver Fever.
Preventing Transmission of Chagas Disease in the U.S. Blood Supply: A Cost Effectiveness Analysis of Testing the Blood Bank Donations Danielle Doughman.
Global Health Malaria. Transmission Malaria is spread by mosquitoes carrying parasites of the Plasmodium type. Four species of Plasmodium are responsible.
Rauni Ruohonen FILHA Priorities of TB control in penitentiary care.
Leptospirosis studies in SAR: CIP highlights from Nepal and Sri Lanka Regional Training in Animal and Human Health Epidemiology in South Asia.
Transmission of Zika Virus Cassandra Salgado, MD, MS, FIDSA, FSHEA Professor of Medicine and Public Health Division Director, Infectious Diseases Medical.
Insect-borne diseases in the news:
Leishmaniasis Thomas Fourie MD M. Taher Shabani-Rad MD CLS, Division of Hematopathology.
Whole-Genome Sequencing; It’s Not Just For Epis
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
Trypanosomiasis Trypanosoma brucei (African trypanosomes)
Copyright © 2017 American Academy of Pediatrics.
Relationship between CMV & PU disease
Trypanosoma cruzi Chagas’ Disease
Chagas Disease Ashleigh Dixon.
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Chagas Disease Will yokeley.
Trypanosomiasis [2] American Trypanosomiasis [Chagas’ disease]:
CHAGAS DISEASE.
Pathogenic Protozoa.
Presentation transcript:

Chagas Disease in the United States FDA BPAC meeting, 1 April 2009 Susan P. Montgomery, DVM MPH LCDR, USPHS Parasitic Diseases Branch Centers for Disease Control and Prevention Atlanta, GA

Trypanosoma cruzi Protozoan parasite only found in the Americas, causes Chagas disease Vector-borne zoonosis, humans not necessary to cycle Infects >100 domestic and wild mammals –Typical hosts: opossums, wood rats, raccoons, dogs, cats Infection of host and vector is life-long Enormous domestic and sylvatic reservoirs

Distribution of vectors and disease Endemic for human Chagas disease Infected vectors, nonhuman mammals

Chagas disease worldwide Programs in Latin America focus on controlling transmission –Vector control –Blood safety WHO Global Network for Chagas disease formed in 2007 –Drug donation (nifurtimox) to WHO –Unique situation in the U.S.

Acute phase of Chagas disease T. cruzi infection weeks Infection remains life-long if untreated Asymptomatic: > 90%Symptomatic: <10% Chronic phase Clinically manifest Chagas disease Chagas heart disease Chagas gastrointestinal disease % remain in indeterminate form throughout life Can reactivate if immunosuppressed Indeterminate form (asymptomatic, normal H&P, ECG) % progress over years - decades

Clinical testing challenges No gold standard test for diagnosis –Serological testing limited availability and varied sensitivity and specificity –Specific skill necessary for parasitological diagnosis (acute infection, reactivation disease) No test to identify which patients will progress from indeterminate form to clinical disease No test to determine cure with antiparasitic treatment

Risk of infection in the U.S. Estimated 300,000 infected immigrants in U.S.* Who is at risk of infection in the U.S. –People exposed to infected vectors and/ or reservoirs –Children of infected mothers –Transplant recipients –Transfusion recipients –Laboratory staff working with vectors, reservoir species, or parasite *Bern and Montgomery, manuscript submitted

History of bugs and T. cruzi in the United States 1855 – Vector bugs identified in Georgia 1860’s / 70’s – Vector bugs identified in six more states 1909 – Discovery of parasite and disease (Brazil) 1916 – Parasite first observed in California 1930’s – Reservoir host infections studied in U.S – First autochthonous cases of Chagas disease reported

States with documented potential T. cruzi vectors ~ 11 potential vector species in the U.S.

States with documented mammalian reservoirs > 18 infected reservoir species identified * * * * * Published human vector- associated cases

Vector and Chagas disease in Texas* 30 mm Female Triatoma gerstaekeri Male Triatoma sanguisuga *Kjos et al. VBZD 2009 Photo courtesy of Sonia Kjos Overall, 50% of tested bugs positive for T. cruzi

Vector-borne transmission in the U.S. Seven autochthonous human cases published YearStatePatient 1955Texasinfant 1955Texasinfant 1982California56 year old woman 1983Texasinfant 1998Tennesseeinfant 2006Louisiana74 year old woman 2006Texasinfant

Published U.S. autochthonous cases: Acute infections Age range 2 weeks to 84 years, 4 male 4 presented with acute symptoms –Non-specific febrile illness –Myocarditis, pericardial effusion 2 primary complaint of bug bites –Fever within 48 hours of bug identification 1 unclear clinical history Triatomines on property in 5 cases; infected reservoir animals on property in 4 cases

Autochthonous infections in U.S. blood donors 2007 Investigation of two blood donors in Mississippi Ongoing study to investigate potentially autochthonous cases, U.S.– Derived T. cruzi Infection Study (USTC) –Designed in collaboration with American Red Cross and Blood Systems Laboratories –Participants will be tested with blood center and CDC tests

Travel-associated infection 26yo Canadian woman returned from 6 months in rural Mexico with acute Chagas disease (Romana’s sign) 56yo Californian man asymptomatic positive blood donor, three international trips each < 2 wks –Two trips to Mexico, one to non-endemic area of South America

Congenital transmission in the U.S. No confirmed cases in U.S. –3 possible cases reported –Case reports from other non-endemic areas Congenital transmission 1 – 10% in endemic areas Usually asymptomatic or non-specific findings –Low birth weight, hepatosplenogmegaly, respiratory distress, anemia, fever Estimate 63 – 315 infected infants per year in U.S.* *Bern and Montgomery, manuscript submitted

Transplant transmission in the U.S. Five published cases 24 recipients of solid organs from seropositive donors in U.S. –Heart –Liver –Kidney –Pancreas/ kidney, liver/ kidney, pancreatic islet 7 (41 %) of 19 recipients became infected

Transfusion transmission in the U.S. and Canada 7 transfusion transmission cases reported in U.S. and Canada Likely under-recognized and under-reported YearRecipient residenceCountry of donor 1987CaliforniaMexico 1989New York CityBolivia 1989ManitobaParaguay 1993Houstonunknown 1999MiamiChile 2000ManitobaParaguay 2002Rhode IslandBolivia

Laboratory-associated transmission in the U.S. Possible exposures –Feces of infected triatomenes –Handling cultures from infected persons or animals –Routes of entry Needlesticks Existing micro-abrasions on skin Mucus membranes Inhaling aerosolized organisms? 8 cases reported in the U.S. –3 needlesticks –3 contact with infectious material and break in skin –2 unknown

Chagas disease may not be recognized in the U.S. Most physicians not familiar with Chagas disease –Recent ACOG survey –Medscape surveys –Community-based organization focus groups Even clinical Chagas disease is not diagnosed –Up to 14% of Hispanic cardiac patients found to be positive for Chagas disease (screened for typical EKG changes)

U.S. public health and Chagas disease Not nationally notifiable –Reportable only in AZ, soon in MA No systematic public health surveillance –AABB Biovigilance system Competing priorities at public health departments Lack of public health testing capacity for Chagas disease

2007 – 2008 CDC consultations and drug releases for Chagas-positive blood donors 45 drug releases 115 consultations ( 19 suspected autochthonous infections) Total of 765 RIPA-positive blood donors* * AABB Chagas Biovigilance reporting system

Clinical patient releases Blood donor releases Blood donor screening starts * as of March 25, 2009 CDC Nifurtimox releases by year 1997 – 2009* *

Challenges to be addressed Improve healthcare provider awareness of Chagas disease –Diagnose clinical disease –Recognize transfusion transmission –Screen for transplant transmission risk Quantify burden of clinical disease in U.S. –Cardiac disease burden –Gastrointestinal disease burden

Risk of Trypanosoma cruzi infection in the U.S. No estimates because insufficient data Requires studies to investigate risk of T. cruzi infection by mode of transmission –Autochthonously –During travel –Transfusion-associated –Congenitally

Thanks to Sonia Kjos, CDC and TX DSHS Paul Cantey, CDC Caryn Bern, CDC The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention.